STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,045,570 | -63.3% | 265,373 | -1.0% | 0.00% | -100.0% |
Q2 2023 | $2,850,274 | +73.9% | 268,135 | +36.3% | 0.00% | – |
Q1 2023 | $1,639,185 | -10.5% | 196,781 | -0.9% | 0.00% | – |
Q4 2022 | $1,832,303 | -29.9% | 198,516 | -2.6% | 0.00% | -100.0% |
Q3 2022 | $2,615,000 | -3.8% | 203,715 | -1.0% | 0.00% | 0.0% |
Q2 2022 | $2,719,000 | -30.8% | 205,801 | +10.3% | 0.00% | 0.0% |
Q1 2022 | $3,929,000 | -12.1% | 186,635 | +0.1% | 0.00% | 0.0% |
Q4 2021 | $4,472,000 | -6.0% | 186,384 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $4,756,000 | -28.4% | 186,942 | -5.2% | 0.00% | 0.0% |
Q2 2021 | $6,639,000 | -8.4% | 197,252 | +5.7% | 0.00% | 0.0% |
Q1 2021 | $7,250,000 | -41.5% | 186,660 | -6.7% | 0.00% | -50.0% |
Q4 2020 | $12,384,000 | +90.1% | 199,970 | +2.8% | 0.00% | +100.0% |
Q3 2020 | $6,516,000 | +43.9% | 194,557 | +2.4% | 0.00% | 0.0% |
Q2 2020 | $4,527,000 | -1.7% | 189,960 | -5.6% | 0.00% | 0.0% |
Q1 2020 | $4,607,000 | +38.6% | 201,137 | +71.3% | 0.00% | 0.0% |
Q4 2019 | $3,325,000 | +43.4% | 117,404 | +8.8% | 0.00% | 0.0% |
Q3 2019 | $2,319,000 | – | 107,896 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |